Several T-cell phenotypes and functional markers have been investigated as potential prognostic and predictive factors in breast cancer, such as CD8+ T-cells [11, 12], FoxP3 [13, 14] and the ζ-chain of the T-cell receptor (see Additional file 1: Table S1) [15–17]. This evidence concerns the gene FOXP3 and breast carcinoma.